On the other hand, we found that LR-TB patients presented the highest percentages of CD14++CD16+ (Figure 1B) and CD14+CD16++ (Figure 1C) circulating cells as compared to HR-TB and HD subjects. This evidence concerns the gene FCGR3A and tuberculosis.